NittoBest Corporation (TYO:2877)
757.00
+3.00 (0.40%)
Sep 4, 2026, 3:04 PM JST
NittoBest Revenue
NittoBest had revenue of 13.97B JPY in the quarter ending June 30, 2026, a decrease of -0.29%. This brings the company's revenue in the last twelve months to 57.45B, up 1.81% year-over-year. In the fiscal year ending March 31, 2026, NittoBest had annual revenue of 57.49B with 2.92% growth.
Revenue (ttm)
57.45B
Revenue Growth
+1.81%
P/S Ratio
0.16
Revenue / Employee
31.22M
Employees
1,840
Market Cap
9.12B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 57.49B | 1.63B | 2.92% |
| Mar 31, 2025 | 55.86B | 1.59B | 2.93% |
| Mar 31, 2024 | 54.27B | 2.39B | 4.61% |
| Mar 31, 2023 | 51.88B | 2.13B | 4.29% |
| Mar 31, 2022 | 49.75B | 849.00M | 1.74% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Ahjikan | 51.87B |
| Nichiwa Sangyo | 45.83B |
| Hayashikane Sangyo | 45.06B |
| Yokohama Maruuo | 41.55B |
| Ichimasa Kamaboko | 35.54B |
| AFC-HD AMS Life Science | 33.20B |
| Wakou Shokuhin | 17.62B |
| Silver Life | 16.11B |